Cranston, Anna LWysocka, AdriannaSteczkowska, MartaZadrozny, MaciejPalasz, EwelinaHarrington, Charles RTheuring, FranzWischik, ClaudeRiedel, GernotNiewiadomska, Grazyna2020-08-062020-08-062020-03-30Cranston, A L, Wysocka, A, Steczkowska, M, Zadrozny, M, Palasz, E, Harrington, C R, Theuring, F, Wischik, C, Riedel, G & Niewiadomska, G 2020, 'Cholinergic and inflammatory phenotypes in transgenic tau mouse models of Alzheimer’s Disease and Frontotemporal Lobar Degeneration', Brain Communications, vol. 2, no. 1, fcaa033. https://doi.org/10.1093/braincomms/fcaa0332632-1297ORCID: /0000-0003-2250-3920/work/173415900https://hdl.handle.net/2164/14871All authors have made a substantial, direct and intellectual contribution to the work, and approved it for publication. This work was funded by NCN grant 2014/15/B/NZ4/05041 and WisTa Laboratories Ltd. CH and CW serve as officers in both WisTa Laboratories Ltd. and TauRx Therapeutics Ltd. The sponsor was involved in the design of the study; in the collection, analysis and interpretation of data; and in the writing of the report. The corresponding authors had full access to all the data and had final responsibility for submission of the report for publication.171276293engSDG 3 - Good Health and Well-beingAlzheimer’s diseasecholinergic neuronsfrontotemporal lobar degenerationneuroinflammationtau proteinR MedicineSupplementary DataRJournal article10.1093/braincomms/fcaa03321